Drug News Digest - Mar 25

	Generic-Brand Name Drug Case Goes to Supreme Court The Supreme Court is to decide whether the maker of a brand-name drug can pay a generic-drug company to keep its version off the market. March 24, 2013 -- NYT > U.S.
	U.S. FDA approves Cangene's treatment for botulism U.S. health regulators on Friday approved the first ever antibody that can counteract the effect of all types of toxins known to cause botulism, a ... March 23, 2013 -- Reuters
	U.S. FDA suggests charging fees to pay for oversight The head of the U.S. Food and Drug Administration proposed on Friday that the agency charge fees to compounding pharmacies to pay for the oversigh ... March 22, 2013 -- Reuters
	New Botox alternative in the war on wrinkles Johnson & Johnson may soon cause frown lines at Allergan Inc, maker of Botox. J&J expects to seek U.S. approval next year for an anti-wrinkle drug ... March 24, 2013 -- Reuters
	AAN: Birth Control Tied to Blood Clots in Migraines Women who suffer from migraines, and migraines with aura in particular, may have an elevated risk of thrombotic complications when they use combin ... March 24, 2013 -- MedPage Today
•	EU new drug approval studies "have too few patients to evaluate safety"